Baptist Health Herbert Wertheim Cancer Institute Treats Its 100th CAR T-Cell Therapy Patient - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Baptist Health Herbert Wertheim Cancer Institute Treats Its 100th CAR T-Cell Therapy Patient

  • By

  • November 16, 2026

  • 4 min

Share

  • 1

    Baptist Health Herbert Wertheim Cancer Institute has treated its 100th patient with CAR T-cell therapy.

  • 2

    CAR T-cell therapy modifies a patient’s T cells to recognize cancer cells, expands them in a laboratory, and infuses them back after preparatory chemotherapy.

  • 3

    The Institute’s CAR T-cell program operates under the leadership of Guenther Koehne, MD, PhD, and relies on collaboration across clinical and support teams.

  • 4

    The Institute has onsite cell processing in a certified Good Manufacturing Practice laboratory, and its Blood and Marrow Stem Cell Transplant Program is FACT accredited.

  • 5

    The Institute’s program is part of the Memorial Sloan Kettering Cancer Alliance and provides dedicated inpatient bone marrow and immunotherapy care at Hope Tower.

Original Source(s)

Related Content